Literature DB >> 26347283

National serosurvey of encephalomyocarditis virus in healthy people and pigs in China.

Ruofei Feng1, Jia Wei2, Haixia Zhang2, Jingjing Fan2, Xiangrong Li2, Dan Wang2, Jingying Xie2,3, Zilin Qiao1, Mingsheng Li1, Jialin Bai1, Zhongren Ma4.   

Abstract

Encephalomyocarditis virus (EMCV) is a zoonotic pathogen that has a wide spectrum of host range. The virus has been discovered on swine farms worldwide and can cause acute fatal myocarditis in piglets and reproductive disorders in sows. Although EMCV infection has been documented in farmed pigs in China, seroprevalence in humans has not been reported. In this study, we conducted nationwide serological surveys for EMCV in humans and farmed pigs in China in 2013, by the use of a double antigen sandwich ELISA method. A total of 3305 serum samples from healthy people were obtained from seven geographical regions in China, of which 1010 samples (30.56%) were positive for EMCV antibodies. The overall seroprevalence for EMCV in the age groups of 0-20, 21-40, 41-60 and >60 years were 13.5%, 30.25%, 36.83% and 38.71% respectively, showing a tendency of increasing with age (P = 0.000). A total of 3470 serum samples from farmed pigs were collected and tested for antibodies to EMCV. A high seroprevalence of 77% was recorded, and significant regional differences were observed. It was concluded that people and pigs in China were commonly infected by EMCV. In addition, in order to characterize changes of seroprevalence during natural EMCV infection in pigs, 240 serial serum samples were collected from 30 pigs (at 0, 15, 30, 60, 75, 90, 120, and 150 days of age) in a farrow-to-finish farm in China. The data showed that there were two EMCV antibody peaks: the first peak appeared at day 30, followed by a decrease in EMCV antibody titer, and the second occurred after day 75. Thus, the most susceptible period of pigs for EMCV infection was between day 30 and day 75 of age.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26347283     DOI: 10.1007/s00705-015-2591-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  Predictors of human-infective RNA virus discovery in the United States, China, and Africa, an ecological study.

Authors:  Feifei Zhang; Margo Chase-Topping; Chuan-Guo Guo; Mark E J Woolhouse
Journal:  Elife       Date:  2022-06-06       Impact factor: 8.713

2.  Evaluation of a duplex reverse-transcription real-time PCR assay for the detection of encephalomyocarditis virus.

Authors:  Shaomin Qin; Darren Underwood; Luke Driver; Carol Kistler; Ibrahim Diallo; Peter D Kirkland
Journal:  J Vet Diagn Invest       Date:  2018-06-02       Impact factor: 1.279

3.  Isolation and Characterization of Encephalomyocarditis Virus from Dogs in China.

Authors:  Ya-Kun Luo; Lin Liang; Qing-Hai Tang; Ling Zhou; Li-Jun Shi; Ying-Ying Cong; Wen-Cheng Lin; Shang-Jin Cui
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

4.  Transcriptional profiling of host cell responses to encephalomyocarditis virus (EMCV).

Authors:  Jia Wei; Haixia Zhang; Xiangrong Li; Qiongyi Li; Zhongren Ma; Jialin Bai; Zilin Qiao; Ruofei Feng
Journal:  Virol J       Date:  2017-03-04       Impact factor: 4.099

5.  Transmembrane Protein 39A Promotes the Replication of Encephalomyocarditis Virus via Autophagy Pathway.

Authors:  Xiangrong Li; Ruixian Ma; Qian Li; Shengjun Li; Haixia Zhang; Jingying Xie; Jialin Bai; Adi Idris; Ruofei Feng
Journal:  Front Microbiol       Date:  2019-11-29       Impact factor: 5.640

6.  HSP27 Protein Dampens Encephalomyocarditis Virus Replication by Stabilizing Melanoma Differentiation-Associated Gene 5.

Authors:  Xiangrong Li; Ruixian Ma; Bei Wu; Yuhui Niu; Hongshan Li; Dianyu Li; Jingying Xie; Adi Idris; Ruofei Feng
Journal:  Front Microbiol       Date:  2021-11-26       Impact factor: 5.640

7.  Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors.

Authors:  Luigi Marongiu; Jonathan J M Landry; Tobias Rausch; Mohammed L Abba; Susanne Delecluse; Henri-Jacques Delecluse; Heike Allgayer
Journal:  Mol Oncol       Date:  2021-08-30       Impact factor: 6.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.